Drug intelligence / Profile preview

Siliphos

Development stage
Unknown
Lead developer
Indena
Modality
Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Oral, Topical
01

Overview

Siliphos is a patented dietary supplement and botanical extract that combines silybin (the most active flavonoid from milk thistle, Silybum marianum) with phospholipids (phosphatidylcholine) to form a highly bioavailable complex. This formulation significantly enhances the absorption and bioavailability of silybin compared to standard milk thistle or silymarin extracts. The primary mechanism of action is antioxidant activity—neutralizing free radicals and protecting liver cells from oxidative stress—and supporting detoxification processes in the liver. Siliphos also stimulates protein synthesis in hepatocytes and helps maintain normal levels of glutathione, contributing to overall liver health. It is primarily used for liver support but has also been marketed as a natural alternative to retinoids for skin health due to its effects on collagen production and wrinkle reduction[1][2][3][4][5][6][8][9][10].

Brand names
Siliphos
Other names
silybin-phytosomesilybin phytosomemilk thistle phytosomeSilybum marianum extract/phospholipid complex

Beyond the preview

Go deeper on Siliphos.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Siliphos.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call